ICMRA outlines shape of Phase 3 COVID-19 vaccine trials - Regulatory Focus 10-Jul-2020

ICMRA outlines shape of Phase 3 COVID-19 vaccine trials - Regulatory Focus

A new report provides a roadmap for Phase 3 clinical trials for developers of candidate vaccines for the novel coronavirus SARS-CoV-2, the virus that causes COVID-19. The report indicates which clinical and preclinical data will indicate a vaccine is ready fo…